Application 210396
- Type
- ANDA
- Sponsor
- TORRENT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SILODOSIN | SILODOSIN | CAPSULE;ORAL | 4MG | No | No |
| 002 | SILODOSIN | SILODOSIN | CAPSULE;ORAL | 8MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210396-001 | SILODOSIN | SILODOSIN | 4MG | CAPSULE / ORAL | 2025-02-10 | ||
| A210396-002 | SILODOSIN | SILODOSIN | 8MG | CAPSULE / ORAL | 2025-02-10 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A210396-001 | SILODOSIN | 4MG | CAPSULE / ORAL | 2025-02-10 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A210396-002 | SILODOSIN | 8MG | CAPSULE / ORAL | 2025-02-10 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A210396-001 | SILODOSIN | 4MG | CAPSULE / ORAL | 2025-02-10 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A210396-002 | SILODOSIN | 8MG | CAPSULE / ORAL | 2025-02-10 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A210396-001 | SILODOSIN | 4MG | CAPSULE / ORAL | 2025-02-10 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A210396-002 | SILODOSIN | 8MG | CAPSULE / ORAL | 2025-02-10 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210396-001 | SILODOSIN | 4MG | CAPSULE / ORAL | 2025-02-10 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A210396-002 | SILODOSIN | 8MG | CAPSULE / ORAL | 2025-02-10 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210396-001 | SILODOSIN | 4MG | CAPSULE / ORAL | 2025-02-10 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A210396-002 | SILODOSIN | 8MG | CAPSULE / ORAL | 2025-02-10 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210396-001 | SILODOSIN | 4MG | CAPSULE / ORAL | AB | 2025-02-10 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210396-002 | SILODOSIN | 8MG | CAPSULE / ORAL | AB | 2025-02-10 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210396-001 | SILODOSIN | 4MG | CAPSULE / ORAL | AB | 2025-02-10 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210396-002 | SILODOSIN | 8MG | CAPSULE / ORAL | AB | 2025-02-10 | b8a1b40f171c… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210396-001 | SILODOSIN | 4MG | CAPSULE / ORAL | 2025-02-10 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210396-002 | SILODOSIN | 8MG | CAPSULE / ORAL | 2025-02-10 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210396-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A210396-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210396-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A210396-002 | AB | 1 | b8a1b40f171c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SILODOSIN | SILODOSIN | Novadoz Pharmaceuticals LLC | ee8d577e-948d-4164-9671-c876544ac83b | 2026-08-18 | Warnings, Adverse reactions | SILODOSIN SILODOSIN |
| Silodosin | SILODOSIN | Bryant Ranch Prepack | afbf4823-8663-4152-9346-ca42c7b7d722 | 2026-07-07 | Warnings, Adverse reactions | Silodosin SILODOSIN |
| SILODOSIN | SILODOSIN | Creekwood Pharmaceuticals LLC | 43f83422-680f-411e-bbc3-2b092e64a017 | 2026-05-07 | Warnings, Adverse reactions | SILODOSIN SILODOSIN |
| Silodosin | SILODOSIN | Amneal Pharmaceuticals NY LLC | de619e27-9384-4b86-abdc-de0557cd39e8 | 2026-04-15 | Warnings, Adverse reactions | Silodosin SILODOSIN |
| SILODOSIN | SILODOSIN | Bryant Ranch Prepack | aac3314b-af8c-400e-ba91-0cf2b95e70dd | 2026-03-16 | Warnings, Adverse reactions | SILODOSIN SILODOSIN |
| SILODOSIN | SILODOSIN | Bryant Ranch Prepack | f2aa0cee-819d-45e8-95b3-86bc63b68368 | 2026-03-16 | Warnings, Adverse reactions | SILODOSIN SILODOSIN |
| Silodosin | SILODOSIN | AvKARE | ea3bbafb-d32a-d0d3-e053-2a95a90ac387 | 2026-01-15 | Warnings, Adverse reactions | Silodosin SILODOSIN |
| Silodosin | SILODOSIN | Ajanta Pharma USA Inc. | e863be56-d303-43bb-915a-1b2568674e31 | 2025-11-28 | Warnings, Adverse reactions | Silodosin SILODOSIN |
| SILODOSIN | SILODOSIN | PD-Rx Pharmaceuticals, Inc. | 94bca72c-c74a-4181-8b6a-a0a2f654a0a7 | 2025-10-09 | Warnings, Adverse reactions | SILODOSIN SILODOSIN |
| Silodosin | SILODOSIN | Lupin Pharmaceuticals, Inc. | 2300db48-477f-4357-8de9-f723737071b4 | 2025-10-07 | Warnings, Adverse reactions | Silodosin SILODOSIN |
| SILODOSIN | SILODOSIN | PD-Rx Pharmaceuticals, Inc. | 365a86b3-748a-465d-b489-dba1479be670 | 2025-10-02 | Warnings, Adverse reactions | SILODOSIN SILODOSIN |
| Silodosin | SILODOSIN | Camber Pharmaceuticals, Inc. | b9880aad-5fbe-470b-a7a0-d963ba4bc98b | 2024-06-05 | Warnings, Adverse reactions | Silodosin SILODOSIN |
| SILODOSIN | SILODOSIN | Aurobindo Pharma Limited | 5e5038ea-9214-469b-8174-e5787be7a801 | 2024-05-08 | Warnings, Adverse reactions | SILODOSIN SILODOSIN |
| Silodosin | SILODOSIN | Alembic Pharmaceuticals Limited | 322ce16e-485f-4fd2-bb30-6b4776bc9e85 | 2023-01-30 | Warnings, Adverse reactions | Silodosin SILODOSIN |
| Silodosin | SILODOSIN | Macleods Pharmaceuticals Limited | 58af9a98-b1a1-4f30-b535-6647f1effed4 | 2022-06-28 | Warnings, Adverse reactions | Silodosin SILODOSIN |
| Silodosin | SILODOSIN | Amneal Pharmaceuticals NY LLC | 455c98be-aa01-4393-915f-34d1859005c0 | 2022-04-28 | Warnings, Adverse reactions | Silodosin SILODOSIN |
| Silodosin | SILODOSIN | Alembic Pharmaceuticals Inc. | 9a4d0d64-39bc-4d16-b040-8554eff19ee3 | 2021-07-15 | Warnings, Adverse reactions | Silodosin SILODOSIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.